Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
40.79
-1.56 (-3.68%)
At close: Feb 27, 2026, 4:00 PM EST
41.11
+0.32 (0.78%)
After-hours: Feb 27, 2026, 7:22 PM EST
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.91 billion as of February 27, 2026. Its market cap has increased by 33.04% in one year.
Market Cap
2.91B
Enterprise Value
2.27B
1-Year Change
33.04%
Ranking
Category
Stock Price
$40.79
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.91B, an increase of 1,192.03%. That is a compound annual growth rate of 70.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.90B | -19.45% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.34B |
| Tarsus Pharmaceuticals | 3.23B |
| Edgewise Therapeutics | 3.14B |
| Catalyst Pharmaceuticals | 3.04B |
| Beam Therapeutics | 2.87B |
| Viridian Therapeutics | 2.81B |
| Wave Life Sciences | 2.81B |
| IDEAYA Biosciences | 2.80B |